Drona Smith News Today

Family members recently honored Joe Campos Torres, a Mexican American veteran killed by Houston Police Department officers in 1977.

UNION therapeutics’ COVID-19 candidates show promising results in phase 1 study Apr 7 2021 UNION therapeutics A/S (UNION) announced today that the results of a phase 1 study of inhaled and intranasal niclosamide (UNI911) have been published by The Lancet Regional Health – Europe (LINK). With no serious adverse effects reported, the study showed a strong safety profile of inhaled and intranasal niclosamide which was the primary endpoint for the trial. The promising safety and pharmacokinetic...

UNION therapeutics COVID-19 candidates found to be well tolerated in Phase 1 Lancet publication The Lancet Regional Health - Europe has published the results of UNION therapeutics phase 1 study of inhaled and intranasal niclosamide products (UNI91103 and UNI91104) The study endpoints were to assess the safety profile and the pharmacokinetic profile of niclosamide when administered as a nasal spray and as an inhalation product (nebulizer) The study was placebo-controlled and conducted in healthy...

UNI91103,developed by UNION therapeutics A/S,selected as first agent for prophylactic COVID-19 “PROTECT-V” study in high-risk patients UNI91103 is a nasal spray delivering niclosamide - a potent inhibitor of SARS-CoV-2 with in-vitro potency >40x higher than remdesivir - to the nasal cavityUNI9110...

He added: “I’m aware I am lucky. “I am retired, living in a house with a lovely big garden in a remote location, so in lockdown I could garden, walk the dogs, run around the garden to keep fit. “I don’t have the financial pressures of a younger man with small children, concerned not just for health but also finances. “I am also aware that if I was a high-shielder living in a city, I would not have been so relaxed.” Niclosamide is usually taken in tablet form to treat intestinal wo...

/PRNewswire/ -- UNION therapeutics A/S (UNION) has been selected by Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge to...

- UNI91103 has been selected as the first agent to be trialed in a study by UK investigators - If successful, data generated will be used for registration of the product - The study will include approx.1,500 kidney patients to assess if UNI91103 can prevent patients from contracting symptomatic COVID-19 and / or reduce serious illness and death from the infection - Kidney patients are considered a high-risk patient population that may not respond well to vaccination - Niclosamide has been demo...

St Winefrede in Wimbledon features © Benedict Flett Church congregations may be dwindling, but Emma Rose Barber has done her fair of calling in at the House of God. From around 4,000 London churches, shes selected 111 of them to feature in her appropriately-titled book, 111 Churches in London that You Shouldnt Miss. Here are 14 of those churches which she suggests we pay a visit. Fitzrovia Chapel, Fitzrovia © Benedict Flett A few years back most of the hospital, which this chapel was built fo...